Acadia Pharmaceuticals buy JPMorgan Chase & Co.
Start price
17.11.25
/
50%
€20.43
Target price
17.11.26
€26.71
Performance (%)
11.70%
Price
13:16
€22.93
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ currently has a performance of 11.70%. This prediction currently runs until 17.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Acadia Pharmaceuticals | 0.047% |
| iShares Core DAX® | 0.396% |
| iShares Nasdaq 100 | 0.881% |
| iShares Nikkei 225® | 1.405% |
| iShares S&P 500 | 0.259% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target lowered by analysts at JPMorgan Chase & Co. from $33.00 to $31.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.17
29.09.25
29.09.25
€28.15
29.09.26
29.09.26
26.20%
13:16
13:16
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
24.07.25
24.07.25
€28.88
24.07.26
24.07.26
14.65%
13:16
13:16
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.28
06.06.25
06.06.25
€26.22
06.06.26
06.06.26
18.93%
13:16
13:16
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
25.03.24
25.03.24
€23.06
25.03.25
25.03.25
-4.67%
26.03.25
26.03.25